Efficacy of enteral nutrition enriched with eicosapentaenoic acid (Prosure) for the treatment of chemoradiotherapy for head and neck cancer

Efficacy of enteral nutrition enriched with eicosapentaenoic acid (Prosure) for the treatment of chemoradiotherapy for head and neck cancer - Efficacy of enteral nutrition enriched with eicosapentaenoic acid (Prosure) for the treatment of chemoradiotherapy for head and neck cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017288

Enrollment

Registered

2015-04-27

Start date

2013-10-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oropharyngeal carcinoma hypopharyngeal carcinoma

Interventions

enteral nutrition enriched with eicosapentaenoic acid (Prosure)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with oropharyngeal and hypopharyngeal carcinoma treated with chemoradiotherapy using concomitant cisplatin

Exclusion criteria

Exclusion criteria: The patients with severe comobility

Design outcomes

Primary

Measure	Time frame
the maximam body weight loss during the treatment	—

Secondary

Measure	Time frame
the ratio of the patients with mucositis and dermatitis during the treatment	—

Countries

Japan

Contacts

Public ContactTakatsugu Mizumachi

Hokkaido University Hospital otorhinolaryngology

mizumati@med.hokudai.ac.jp011-706-5958

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026